NCT00301509View on ClinicalTrials.gov

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Study Completion Date

December 31, 2005

Conditions
Liver Cirrhosis, Experimental
Interventions
DRUG

peginterferon and ribavirin

Trial Locations (1)

71013

Department of Hepatogastroenterology, CSS, San Giovanni Rotondo

All Listed Sponsors
lead

Casa Sollievo della Sofferenza IRCCS

OTHER

NCT00301509 - Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis | Biotech Hunter | Biotech Hunter